Northrim BanCorp (NRIM) is a Great Momentum Stock: Should You Buy?

Northrim BanCorp (NRIM), the holding company for Northrim Bank, registers a Zacks Momentum Style Score of B and a Zacks Rank #1 (Strong Buy) after pronounced recent strength — shares are up 13.9% over the past week, 18.4% month-to-date, 21.4% over the quarter and 29.3% over the past year, outperforming the Zacks Banks–West industry and the S&P 500; 20-day average volume is ~127,600 shares. Analysts have revised estimates modestly higher in the last 60 days (one upward revision boosting the full-year consensus from $2.35 to $2.50, and one upward revision for the next fiscal year), and Zacks cites the combination of price momentum and positive estimate revisions as the basis for its bullish, near-term view.

Analysis

Zacks Research assigns Northrim BanCorp (NRIM) a Momentum Style Score of B and a Zacks Rank #1 (Strong Buy) based on recent price strength and limited upward estimate revisions. Shares have climbed 13.89% over the past week, 18.37% over the past month, 21.44% over the quarter and 29.31% over the last year, outperforming the Zacks Banks - West industry (week +3.18%, month +7.3%) and the S&P 500 (quarter +4%, year +14.09%). The 20-day average volume is 127,601 shares, indicating modest trading participation behind the move.

Analyst activity has been limited but constructive: in the past 60 days one full-year earnings estimate rose, lifting the consensus from $2.35 to $2.50, and one next-fiscal-year estimate also moved higher with no downgrades. The price momentum combined with these incremental upgrades supports Zacks’ near-term bullish view, but the magnitude and frequency of revisions are small and the Momentum Score is a B rather than an A. Given a market impact score of 0.28, the move may be driven more by technical flows than by a broad fundamental re-rating.

Implications are tactical rather than structural: continued upside likely depends on sustained above-average volume and follow-on estimate upgrades, while a sharp reversal could occur if momentum stalls or earnings guidance disappoints. Investors should treat NRIM as a momentum-driven opportunity backed by modest fundamental improvement and monitor short-term liquidity and revision trends closely.

Key Decisions for Investors

• Consider a tactical accumulation of NRIM given the strong short-term outperformance and Zacks #1 rank, but size initial exposure modestly and use disciplined position limits because momentum can reverse quickly
• Require confirmatory signs—sustained above-average 20-day volume and additional upward EPS revisions—before materially increasing exposure
• If already long, consider trimming into further rallies to crystallize gains or reallocate to higher-conviction opportunities if analyst activity and estimate momentum do not continue